Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Celecoxib for rheumatoid arthritis.

Garner S, Fidan D, Frankish R, Judd M, Shea B, Towheed T, Wells G, Tugwell P.

Cochrane Database Syst Rev. 2002;(4):CD003831. Review. Update in: Cochrane Database Syst Rev. 2017 Jun 09;6:CD003831.

PMID:
12519610
2.

WITHDRAWN: Celecoxib for rheumatoid arthritis.

Garner SE, Fidan D, Frankish RR, Judd M, Shea B, Towheed T, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2017 Jun 9;6:CD003831. doi: 10.1002/14651858.CD003831.pub2. Review.

PMID:
28598564
3.

Rofecoxib for rheumatoid arthritis.

Garner SE, Fidan DD, Frankish RR, Judd MG, Towheed TE, Wells G, Tugwell P.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003685. Review.

PMID:
15674912
4.

Rofecoxib for the treatment of rheumatoid arthritis.

Garner S, Fidan D, Frankish R, Judd M, Towheed T, Wells G, Tugwell P.

Cochrane Database Syst Rev. 2002;(3):CD003685. Review. Update in: Cochrane Database Syst Rev. 2005;(1):CD003685.

PMID:
12137705
5.

Rofecoxib for the treatment of rheumatoid arthritis.

Garner S, Fidan D, Frankish R, Judd M, Towheed T, Wells G, Tugwell P.

Cochrane Database Syst Rev. 2002;(2):CD003685. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD003685.

PMID:
12076502
6.

Rofecoxib for osteoarthritis.

Garner SE, Fidan DD, Frankish R, Maxwell L.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD005115. Review.

PMID:
15654705
8.

Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.

Miao XP, Li JS, Ouyang Q, Hu RW, Zhang Y, Li HY.

Cochrane Database Syst Rev. 2014 Oct 23;(10):CD007744. doi: 10.1002/14651858.CD007744.pub2. Review.

PMID:
25340915
9.

Celecoxib for rheumatoid arthritis.

Fidahic M, Jelicic Kadic A, Radic M, Puljak L.

Cochrane Database Syst Rev. 2017 Jun 9;6:CD012095. doi: 10.1002/14651858.CD012095.pub2. Review.

PMID:
28597983
10.

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS.

JAMA. 2000 Sep 13;284(10):1247-55.

PMID:
10979111
11.

Upper gastroduodenal ulceration in arthritis patients treated with celecoxib.

Ashcroft DM, Chapman SR, Clark WK, Millson DS.

Ann Pharmacother. 2001 Jul-Aug;35(7-8):829-34. Review.

PMID:
11485128
12.

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS.

JAMA. 1999 Nov 24;282(20):1921-8.

PMID:
10580457
13.

Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.

Grabosch SM, Shariff OM, Wulff JL, Helm CW.

Cochrane Database Syst Rev. 2014 Apr 9;(4):CD004121. doi: 10.1002/14651858.CD004121.pub3. Review.

PMID:
24715225
14.

Non-steroidal anti-inflammatory drugs for chronic low back pain.

Enthoven WT, Roelofs PD, Deyo RA, van Tulder MW, Koes BW.

Cochrane Database Syst Rev. 2016 Feb 10;2:CD012087. doi: 10.1002/14651858.CD012087. Review.

PMID:
26863524
16.

Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDs.

Niculescu L, Li C, Huang J, Mallen S.

Curr Med Res Opin. 2009 Mar;25(3):729-40. doi: 10.1185/03007990802714382 .

PMID:
19210159
17.

Acetaminophen for osteoarthritis.

Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004257. Review.

PMID:
16437479
18.
19.
20.

Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.

Clemett D, Goa KL.

Drugs. 2000 Apr;59(4):957-80. Review. Erratum in: Drugs 2001;61(4):498.

PMID:
10804043

Supplemental Content

Support Center